Axsome Thera (AXSM) Stock Price, Quote & News

Company Profile

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptak...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 332 3241

Fax: 212 320 0245

Website: www.axsome.com

Address:

One World Trade Center, 22nd Floor, New York, United States

Wigglyick Nov. 29 at 8:39 PM

$AXSM monthly chart back to 2019. Clean test of the bottom channel line then to a breakout this month.

0 · Reply

MoneyGroupLLC Nov. 29 at 9:47 AM

Enter: $AXSM Calls Strike Price: $155 Expiry Date: DEC 19 2025 Buy in Price: $4.30 - $4.51 Sell Price: $8.34 Profit : +94% (Turn every $1 into $1.94) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

Choovachok Nov. 29 at 8:57 AM

$ESPR Summit Therapeutics ($SMMT) — Market Cap - 13bUSD. Not profit Axsome Therapeutics ($AXSM) - 7,6bUSD. Not profit Viking Therapeutics ($VKTX) - 4bUSD. Not profit !!!Esperion therapeutic ($ESPR) 0,9b USD!!!!. Almost profit. We need be 10-15 bUSD (40-60$ per share)

1 · Reply

11thestate Nov. 28 at 8:52 PM

$AXSM has reached a 7.75M settlement with $AXSM investors over claims that it misled them about regulatory risks related to the company’s migraine drug AXS-07. The filing deadline is February 3, 2026. If you bought $AXSM between December 30, 2019 and April 22, 2022, you can file for payment here: https://11th.com/cases/axsome-investor-settlement

0 · Reply

Vakeshka Nov. 28 at 7:05 PM

$AXSM 16,800 - new record!

0 · Reply

Its_Always_Rainy_Season_ Nov. 28 at 4:46 PM

$AABB $ALT $AXSM $IBRX

0 · Reply

Crimson_Phoenix Nov. 28 at 4:30 PM

$AXSM What're the odds we make another ATH before the day is out .... ?

1 · Reply

Mike826_1999 Nov. 28 at 1:14 PM

$AXSM Axsome: Auvelity for major depressive disorder Weekly TRx grew 4% w/w to 16,800, +36% Y/Y, and rolling 12-wk +44% Y/Y New prescriptions (NRx) / TRx were 58% for the week

5 · Reply

pvll Nov. 28 at 12:34 PM

$AXSM very happy Thanksgiving, indeed. 200 by Christmas.

1 · Reply

InvestinPeace Nov. 28 at 10:32 AM

$CRMD Capitulating. Turned positive earnings. Biotech tail winds 👀. Shorts need to cover soon. $BIIB $AXSM $GILD

0 · Reply

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Nov 10, 2025, 4:45 AM EST - 20 days ago

2 Monster Stocks in the Making

VKTX

Nov 6, 2025, 7:00 AM EST - 24 days ago

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

Nov 6, 2025, 7:00 AM EST - 24 days ago

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

FBIO

Nov 5, 2025, 3:12 PM EST - 24 days ago

Axsome: Alzheimer's Disease Agitation sNDA Adds Optionality, Not A Thesis Changer

Nov 3, 2025, 2:46 PM EST - 26 days ago

Axsome Therapeutics, Inc. (AXSM) Q3 2025 Earnings Call Transcript

Oct 24, 2025, 11:20 AM EDT - 5 weeks ago

Halper Sadeh LLC Encourages Axsome Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 10, 2025, 4:07 AM EDT - 7 weeks ago

Axsome Therapeutics' Strong Growth And Expanding Pipeline: Why I Assign A Buy Rating

Oct 9, 2025, 7:00 AM EDT - 7 weeks ago

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community

Oct 7, 2025, 7:00 AM EDT - 7 weeks ago

Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3

Sep 30, 2025, 4:10 AM EDT - 2 months ago

Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years

EXEL

Sep 18, 2025, 1:53 AM EDT - 2 months ago

Axsome Therapeutics, Inc. (AXSM) Presents at TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Transcript

Sep 17, 2025, 7:00 AM EDT - 2 months ago

Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025

Sep 8, 2025, 5:49 PM EDT - 2 months ago

Axsome Therapeutics, Inc. (AXSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 4, 2025, 9:00 AM EDT - 3 months ago

Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years

VKTX

Aug 5, 2025, 1:40 PM EDT - 4 months ago

Axsome Therapeutics Analysts Increase Their Forecasts After Q2 Earnings

Aug 4, 2025, 2:50 PM EDT - 4 months ago

Axsome Therapeutics, Inc. (AXSM) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:59 AM EDT - 4 months ago

Axsome (AXSM) Q2 Revenue Soars 72%

Aug 4, 2025, 7:00 AM EDT - 4 months ago

Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 25, 2025, 1:46 PM EDT - 4 months ago

Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy

Jul 21, 2025, 7:30 AM EDT - 4 months ago

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline

Jul 9, 2025, 7:00 AM EDT - 5 months ago

Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4

Jul 7, 2025, 7:00 AM EDT - 5 months ago

Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21

Jun 20, 2025, 7:00 AM EDT - 5 months ago

Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month

Jun 11, 2025, 7:00 AM EDT - 6 months ago

Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025

Jun 5, 2025, 3:19 AM EDT - 6 months ago

2 Soaring Stocks Wth More Upside Potential

SMMT

May 27, 2025, 7:00 AM EDT - 6 months ago

Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd.

May 24, 2025, 6:40 AM EDT - 6 months ago

3 High-Flying Stocks That Could Soar Even More

ALNY SMMT

May 14, 2025, 7:30 PM EDT - 7 months ago

Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis

May 13, 2025, 7:00 AM EDT - 7 months ago

Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone

May 12, 2025, 7:08 AM EDT - 7 months ago

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

VRTX

May 11, 2025, 11:15 AM EDT - 7 months ago

3 Monster Stocks in the Making

IOVA VKTX

May 6, 2025, 12:48 PM EDT - 7 months ago

Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns

May 5, 2025, 11:44 AM EDT - 7 months ago

Axsome Therapeutics, Inc. (AXSM) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:41 AM EDT - 7 months ago

Axsome Therapeutics Clocks Around 60% Topline Growth In Q1

May 5, 2025, 7:00 AM EDT - 7 months ago

Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 1, 2025, 7:00 AM EDT - 7 months ago

Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month

Apr 8, 2025, 7:00 AM EDT - 8 months ago

Axsome Therapeutics to Report First Quarter 2025 Financial Results on May 5

Apr 4, 2025, 7:00 AM EDT - 8 months ago

Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer's Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting

Apr 1, 2025, 1:23 PM EDT - 8 months ago

Why Shares of Axsome Therapeutics Slumped Today

Apr 1, 2025, 7:18 AM EDT - 8 months ago

Axsome's depression treatment fails to meet main goal of late-stage study

Mar 25, 2025, 6:47 PM EDT - 8 months ago

Why Pharma and Biotech Stocks Got Thrashed on Tuesday

AMGN MRK REGN

Mar 25, 2025, 7:13 AM EDT - 8 months ago

Axsome Therapeutics' ADHD drug meets main goal in late-stage study

Mar 21, 2025, 11:36 AM EDT - 9 months ago

Axsome: The Alzheimer's Agitation Program For AXS-05

Feb 24, 2025, 1:34 PM EST - 9 months ago

Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs

Feb 20, 2025, 8:15 AM EST - 10 months ago

Axsome Q4 Earnings: Revenues Rising, Skepticism Lingering

Feb 18, 2025, 11:12 AM EST - 10 months ago

Axsome Therapeutics, Inc. (AXSM) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 8:06 AM EST - 10 months ago

Axsome Therapeutics Revenue Surges 66%

Feb 16, 2025, 9:45 AM EST - 10 months ago

This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?

Feb 11, 2025, 5:20 PM EST - 10 months ago

Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade

TEVA

Wigglyick Nov. 29 at 8:39 PM

$AXSM monthly chart back to 2019. Clean test of the bottom channel line then to a breakout this month.

0 · Reply

MoneyGroupLLC Nov. 29 at 9:47 AM

0 · Reply

Choovachok Nov. 29 at 8:57 AM

1 · Reply

11thestate Nov. 28 at 8:52 PM

0 · Reply

Vakeshka Nov. 28 at 7:05 PM

$AXSM 16,800 - new record!

0 · Reply

Its_Always_Rainy_Season_ Nov. 28 at 4:46 PM

$AABB $ALT $AXSM $IBRX

0 · Reply

Crimson_Phoenix Nov. 28 at 4:30 PM

$AXSM What're the odds we make another ATH before the day is out .... ?

1 · Reply

Mike826_1999 Nov. 28 at 1:14 PM

$AXSM Axsome: Auvelity for major depressive disorder Weekly TRx grew 4% w/w to 16,800, +36% Y/Y, and rolling 12-wk +44% Y/Y New prescriptions (NRx) / TRx were 58% for the week

5 · Reply

pvll Nov. 28 at 12:34 PM

$AXSM very happy Thanksgiving, indeed. 200 by Christmas.

1 · Reply

InvestinPeace Nov. 28 at 10:32 AM

$CRMD Capitulating. Turned positive earnings. Biotech tail winds 👀. Shorts need to cover soon. $BIIB $AXSM $GILD

0 · Reply

Mike826_1999 Nov. 27 at 3:24 PM

$AXSM Happy Thanksgiving! New patent filing published this morning for Mazindol to treat narcolepsy with cataplexy or ADHD. Medical Uses Primary historical use: Short-term (a few weeks) treatment of exogenous obesity in adults with a BMI >30 kg/m² (or >27 kg/m² with risk factors like hypertension or diabetes), combined with diet, exercise, and behavioral changes. Doses typically range from 1–2 mg/day, taken before meals. Off-label and investigational uses: -Narcolepsy and cataplexy: It reduces excessive daytime sleepiness and cataplectic attacks, with efficacy similar to amphetamines. -Attention-deficit/hyperactivity disorder (ADHD): Under investigation in controlled-release forms, with ongoing studies. https://ppubs.uspto.gov/api/patents/html/20250360107?source=US-PGPUB&requestToken=eyJzdWIiOiI5Y2RkMDRlMC0wZGY0LTQyZTctOGMyZS00MGZiZDgxOWZkODEiLCJ2ZXIiOiJjYzMxZWQ2MC0zN2NlLTQ2ZjEtYWY0Zi0zNTBiY2MxYzE2OTkiLCJleHAiOjB9

4 · Reply

pi22dv7 Nov. 27 at 3:13 PM

$AXSM Happy Thanksgiving fellow investors (long, short, opinions only), we spend our precious time on this board from many years ($2 days till now), had some great mentors like Clovus, Mike and others. I am thankful for all your inputs. Let’s have a great year ahead 🙏🏾💪🏾

1 · Reply

jlfromli Nov. 27 at 1:20 PM

$AXSM Happy Thanksgiving You turkeys. 🦃 Lots to be Grateful for. Remember those Who might need A little help during The holidays. ✌️

0 · Reply

MoneyGroupLLC Nov. 27 at 9:45 AM

Enter: $AXSM Calls Strike Price: $155 Expiry Date: DEC 19 2025 Buy in Price: $3.78 - $3.97 Sell Price: $8.50 Profit : +125% (Turn every $1 into $2.25) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

pvll Nov. 26 at 10:39 PM

$AXSM is making me happy

0 · Reply

Live2ride Nov. 26 at 9:30 PM

$AXSM If this has been discussed already I missed it so forgive me... Is there much of a chance the gov't shutdown might delay the sNDA FDA results? Thanks in advance.

1 · Reply

JeffTex Nov. 26 at 9:04 PM

$AXSM I’ll take a $2K daily gain day before Thanksgiving & be grateful ! It was even decent volume considering the upcoming holiday tomorrow

0 · Reply

jgaeth Nov. 26 at 8:44 PM

$AXSM Happy Thanksgiving AXSM family. We have a lot to be thankful for this year. Have a great holiday.

0 · Reply

Crimson_Phoenix Nov. 26 at 5:21 PM

$AXSM Some nice stats for us here, to hopefully somewhat satisfy the 'it never does anything' crowd. 1 Month: Up 11.80% 6 Month: Up 44.74% Yr 2 Date: Up 72.33% Five Year: Up Just Over 100% RAWR ....

0 · Reply

Mike826_1999 Nov. 26 at 5:19 PM

$AXSM We should hear this week, or at least by Monday, whether the AXS-05 for ADA sNDA was accepted or issued an RTF.

3 · Reply

Dman520 Nov. 26 at 4:49 PM

$AXSM saw the Auvelity commercial during dancing with the stars finale!

1 · Reply

jlfromli Nov. 26 at 4:22 PM

$AXSM Closed! $1K Let’s go!

1 · Reply

Market Cap	7.64B
Revenue (ttm)	385.69M
Net Income (ttm)	-287.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-74.47%
Debt to Equity Ratio	1.60

Volume	189,500
Avg Vol	509,486
Day's Range	N/A - N/A
Shares Out	50.41M
Stochastic %K	90%
Beta	0.50
Analysts	Strong Sell
Price Target	$178.74